Sheba Medical Center serves as the first clinical trial site outside of the US Studying Covid Variant Vaccines

Sheba Medical Center will soon serve as the first clinical trial site outside of the US studying vaccines specifically aimed against Omicron and other Covid variants.

Sheba Medical Center will soon serve as the first clinical trial site outside of the US studying vaccines specifically aimed against Omicron and other Covid variants.

Explains Professor Gili Regev-Yochay, Director of the Infection Prevention & Control Unit at Sheba Medical Center, “this trial is extremely important as the world continues to deal with and battle these variants and perhaps others in the future. Vaccinations are the only way to roll back the global coronavirus pandemic.”

Read more here

Whether helping those most in need or advancing healthcare globally:
when you support Sheba, you are making a difference.